Table 1 Patients providing tissue
Patient type | Sex | Age | Mean PA pressure (mmHg) | Medications | PVR (dyne*sec)/cm5 | Lung tissue | |
|---|---|---|---|---|---|---|---|
1 | Control (Benign tumor) | F | 35 | ND | None | ND | Yes |
2 | Control (Lung Cancer) | F | 38 | ND | None | ND | Yes |
3 | Control (Benign tumor) | M | 45 | ND | None | ND | Yes |
4 | Control (Lung Cancer) | M | 51 | ND | None | ND | Yes |
5 | Control (Hodgkin) | M | 48 | ND | None | ND | Yes |
6 | Control (Benign tumor) | F | 44 | ND | None | ND | Yes |
7 | Control (Lung Cancer) | F | 47 | ND | None | ND | Yes |
8 | Control (Lung Cancer) | F | 50 | ND | None | ND | Yes |
9 | iPAH | F | 58 | 56 | Epoprostenol/Lasix/Coumadin | 1709 | Yes |
10 | iPAH | F | 36 | 67 | Epoprostenol/Lasix/Coumadin | 2274 | Yes |
11 | SSC-PAH | F | 55 | 48 | Epoprostenol/Lasix/Coumadin | 980 | Yes |
12 | PAH group1 | F | 64 | 59 | Bosentan/Lasix | 926 | Yes |
13 | PAH group1 | M | 72 | 39 | Lasix/Sitaxsentan | 550 | Yes |
14 | PAH group1 | M | 58 | 42 | Epoprostenol/Lasix/Coumadin | 991 | Yes |
15 | PAH group1 | F | 51 | 51 | Lasix/coumadin | 1199 | Yes |
16 | PAH group1 | F | 48 | 73 | Epoprostenol/Lasix | 1800 | Yes |
17 | PAH group1 | F | 51 | 41 | Lasix | 990 | Yes |
18 | PAH group1 | F | 68 | 37 | Lasix/coumadin/Norvasc | 544 | Yes |